SUZB3:BMFBOVESPASuzano S.A. Analysis
Data as of 2026-03-11 - not real-time
R$54.69
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Suzano (SUZB3) trades at a trailing P/E of just over 5× and a DCF‑derived fair value of roughly R$80, implying about 30% upside from the current price of R$54.69. The stock sits above its 200‑day SMA (R$51.27) and the 50‑day SMA (R$53.32), confirming a bullish medium‑term trend, while the 20‑day SMA (R$56.80) still sits above price, suggesting a short‑term pull‑back. Momentum indicators are mixed – RSI at 47 signals neutral momentum and the MACD histogram is negative, yet the overall trend direction is flagged as bullish. Fundamentally, the company delivers a robust profit margin of 27% and an ROE of 35%, supported by a modest dividend yield of 2% with a low payout ratio of 10%, indicating sustainable income. However, the balance sheet shows a high debt‑to‑equity ratio of over 230× and a negative free‑cash‑flow figure, raising financial risk despite recent news of a $400 M free cash flow in Q4 2025.
The high 30‑day volatility (≈44%) and decreasing volume suggest heightened price swings and liquidity concerns, while a beta of 0.2 points to limited market‑wide risk. Sector‑wise, basic materials are cyclical with medium regulatory exposure due to forest‑management rules, and the company’s Brazil‑centric operations add medium geographic and currency risk. Given the strong valuation upside, solid earnings power, and attractive dividend, the stock is positioned as an undervalued, blended‑growth opportunity, but investors should monitor debt levels and cash‑flow trends.
The high 30‑day volatility (≈44%) and decreasing volume suggest heightened price swings and liquidity concerns, while a beta of 0.2 points to limited market‑wide risk. Sector‑wise, basic materials are cyclical with medium regulatory exposure due to forest‑management rules, and the company’s Brazil‑centric operations add medium geographic and currency risk. Given the strong valuation upside, solid earnings power, and attractive dividend, the stock is positioned as an undervalued, blended‑growth opportunity, but investors should monitor debt levels and cash‑flow trends.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Mixed technical signals with bearish MACD but bullish SMA alignment
- Current price near support and below short‑term SMA
- Recent positive cash‑flow news tempered by high leverage
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Valuation upside of ~30% to DCF fair value
- Strong profitability metrics (ROE 35%, profit margin 27%)
- Sustainable dividend yield with low payout ratio
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Long‑term demand for pulp and paper products
- Undervalued multiple relative to peers and historical averages
- Resilient earnings power despite cyclical sector dynamics
Key Metrics & Analysis
Financial Health
Revenue Growth-7.50%
Profit Margin26.75%
P/E Ratio5.1
ROE35.19%
ROA3.78%
Debt/Equity231.46
P/B Ratio1.5
Op. Cash FlowR$18.2B
Free Cash FlowR$-535921632
Technical Analysis
TrendBullish
RSI47.2
SupportR$51.05
ResistanceR$59.65
MA 20R$56.80
MA 50R$53.32
MA 200R$51.27
MACDBearish
VolumeDecreasing
Fear & Greed Index76.43
Valuation
Fair ValueR$80.75
Target PriceR$71.09
Upside/Downside29.99%
GradeUndervalued
TypeBlend
Dividend Yield2.01%
Risk Assessment
Beta0.21
Volatility43.57%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.